We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
56 hedge funds and large institutions have $84.5M invested in ADMA Biologics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
46% more capital invested
Capital invested by funds: $58M → $84.5M (+$26.5M)
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
8% more funds holding
Funds holding: 52 → 56 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.18% less ownership
Funds ownership: 53.28% → 48.1% (-5.2%)
84% less call options, than puts
Call options by funds: $297K | Put options by funds: $1.81M
Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
15
Reduced
13
Closed
5
Calls
$297K
Puts
$1.81M
Net Calls
-$1.51M
Net Calls Change
-$1.51M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.19M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$795K |
| 3 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
+$619K |
| 4 |
Barclays
London,
United Kingdom
|
+$195K |
| 5 |
Jane Street
New York
|
+$165K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$9.71M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.23M |
| 3 |
DG
Delek Group
Herzliya,
Israel
|
-$193K |
| 4 |
PVI
Pura Vida Investments
New York
|
-$131K |
| 5 |
Morgan Stanley
New York
|
-$90.3K |
